Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec. Reichel FF, Seitz I, Wozar F, Dimopoulos S, et al. Br J Ophthalmol 2022 May 24. pii: bjophthalmol-2021-321023.

Read + Share

Amedeo Smart

Independent Medical Education

Reichel FF, Seitz I, Wozar F, Dimopoulos S, et al. Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec. Br J Ophthalmol 2022 May 24. pii: bjophthalmol-2021-321023.
PMID: 35609955